ProfileGDS4718 / 215751_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 3% 4% 5% 4% 4% 3% 4% 5% 6% 2% 3% 4% 8% 5% 8% 2% 4% 7% 4% 11% 3% 4% 3% 4% 5% 2% 4% 11% 5% 3% 5% 4% 6% 4% 2% 11% 3% 3% 2% 5% 3% 9% 2% 2% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.519953
GSM549102patient 115, normal, homogenized [OPG study]3.549244
GSM549104patient 119, normal, homogenized [OPG study]3.576785
GSM549108patient 138, normal, homogenized [OPG study]3.559294
GSM549119patient 077, normal, homogenized [OPG study]3.535564
GSM549133patient 032, cancer, homogenized [OPG study]3.43843
GSM549139patient 042, cancer, homogenized [OPG study]3.5324
GSM549099patient 107, normal, homogenized [OPG study]3.584745
GSM549109patient 139, normal, homogenized [OPG study]3.657396
GSM549110patient 046, normal, homogenized [OPG study]3.441662
GSM549114patient 063, normal, homogenized [OPG study]3.474383
GSM549122patient 082, normal, homogenized [OPG study]3.540454
GSM549134patient 033, cancer, homogenized [OPG study]3.685798
GSM549136patient 036, cancer, homogenized [OPG study]3.559395
GSM549140patient 044, cancer, homogenized [OPG study]3.670488
GSM549111patient 047, normal, homogenized [OPG study]3.429032
GSM549113patient 057, normal, homogenized [OPG study]3.491474
GSM549132patient 031, cancer, homogenized [OPG study]3.670957
GSM549137patient 038, cancer, homogenized [OPG study]3.523254
GSM549142patient 047, cancer, homogenized [OPG study]3.8936211
GSM549100patient 110, normal, homogenized [OPG study]3.492523
GSM549107patient 135, normal, homogenized [OPG study]3.515644
GSM549115patient 068, normal, homogenized [OPG study]3.457973
GSM549116patient 072, normal, homogenized [OPG study]3.558654
GSM549120patient 078, normal, homogenized [OPG study]3.556265
GSM549131patient 030, cancer, homogenized [OPG study]3.418032
GSM549118patient 074, normal, homogenized [OPG study]3.553984
GSM549129patient 027, cancer, homogenized [OPG study]3.8180811
GSM549123patient 088, normal, homogenized [OPG study]3.616535
GSM549124patient 006, cancer, homogenized [OPG study]3.525673
GSM549126patient 015, cancer, homogenized [OPG study]3.573115
GSM549128patient 025, cancer, homogenized [OPG study]3.520334
GSM549103patient 117, normal, homogenized [OPG study]3.644396
GSM549117patient 073, normal, homogenized [OPG study]3.537874
GSM549138patient 041, cancer, homogenized [OPG study]3.424532
GSM549141patient 045, cancer, homogenized [OPG study]3.779611
GSM549130patient 028, cancer, homogenized [OPG study]3.508033
GSM549101patient 111, normal, homogenized [OPG study]3.445523
GSM549105patient 128, normal, homogenized [OPG study]3.407092
GSM549106patient 134, normal, homogenized [OPG study]3.556245
GSM549112patient 048, normal, homogenized [OPG study]3.491093
GSM549125patient 011, cancer, homogenized [OPG study]3.736619
GSM549127patient 024, cancer, homogenized [OPG study]3.408262
GSM549135patient 035, cancer, homogenized [OPG study]3.402382